USE OF ORSAPONIN 3BETA, 16BETA, 17 ALPHA-TRIHYDROXYCHOLOST-5-EN­22-ONE 16-0-(2-0-4-METHOXYBENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-(2-0­ACETYL-ALPHA-L-ARABINOPYRANOSIDE) OR OSW-1 AND ITS DERIVATIVES FOR CANCER THERAPEUTICS

摘要

The present invention concerns methods for treating pancreatic cancers, leukemias, colon cancers, malignant gliomas and other brain tumors, and ovarian cancers which comprise providing to an individual compositions comprising an orsaponin such as 0SW-1 or its. derivatives such as 17-­deoxyorsaponin. Various therapeutically useful derivatives of orsaponins are also described.